The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase
- 28 November 2005
- journal article
- Published by Elsevier
- Vol. 339 (3) , 865-872
- https://doi.org/10.1016/j.bbrc.2005.11.102
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main ProteasesPLoS Biology, 2005
- Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Synthesis and Evaluation of Keto-Glutamine Analogues as Potent Inhibitors of Severe Acute Respiratory Syndrome 3CLproJournal of Medicinal Chemistry, 2004
- Sabadinine: A Potential Non-Peptide Anti-Severe Acute-Respiratory-Syndrome Agent Identified Using Structure-Aided DesignJournal of Medicinal Chemistry, 2004
- Identifying inhibitors of the SARS coronavirus proteinaseBioorganic & Medicinal Chemistry Letters, 2003
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003
- Size-Distribution Analysis of Macromolecules by Sedimentation Velocity Ultracentrifugation and Lamm Equation ModelingBiophysical Journal, 2000
- Targeting the Dimerization Interface of HIV-1 Protease: Inhibition with Cross-Linked Interfacial PeptidesJournal of the American Chemical Society, 1997
- The inhibition of human immunodeficiency virus proteases by ‘interface peptides’Antiviral Research, 1996
- HIV-1 reproduction is inhibited by peptides derived from the N- and C-termini of HIV-1 proteaseBiochemical and Biophysical Research Communications, 1991